Cargando…

Treatment of Combined Hepatocellular and Cholangiocarcinoma

Combined hepatocellular and cholangiocarcinoma (HCC-CC) is a rare primary liver cancer. It is constituted by neoplastic cells of both hepatocellular and cholangiocellular derivation. Different histology types of HCC-CC have been reported, hinting at heterogeneous carcinogenic pathways leading to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leoni, Simona, Sansone, Vito, De Lorenzo, Stefania, Ielasi, Luca, Tovoli, Francesco, Renzulli, Matteo, Golfieri, Rita, Spinelli, Daniele, Piscaglia, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226028/ https://www.ncbi.nlm.nih.gov/pubmed/32224916 http://dx.doi.org/10.3390/cancers12040794

Ejemplares similares

Experience with regorafenib in the treatment of hepatocellular carcinoma
por: Granito, Alessandro, et al.
Publicado: (2021)

COVID-19: Has the Liver Been Spared?
por: Brandi, Nicolò, et al.
Publicado: (2023)

Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery
por: Goio, Elisabetta, et al.
Publicado: (2020)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials
por: Tovoli, Francesco, et al.
Publicado: (2021)

Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders
por: Ielasi, Luca, et al.
Publicado: (2021)

Hepatocellular adenoma: An unsolved diagnostic enigma
por: Renzulli, Matteo, et al.
Publicado: (2019)

TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma
por: Granito, Alessandro, et al.
Publicado: (2021)

TACE performed in patients with a single nodule of Hepatocellular Carcinoma
por: Terzi, Eleonora, et al.
Publicado: (2014)

Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC
por: Granito, Alessandro, et al.
Publicado: (2021)

Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib
por: Sansone, Vito, et al.
Publicado: (2021)

Hot topics in hepatocellular carcinoma
por: Ielasi, Luca, et al.
Publicado: (2019)

Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma
por: Ielasi, Luca, et al.
Publicado: (2023)

Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
por: Ferri, Silvia, et al.
Publicado: (2022)

The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?
por: Renzulli, Matteo, et al.
Publicado: (2022)

Liver collision lesion: inflammatory hepatocellular adenoma within focal nodular hyperplasia
por: Renzulli, Matteo, et al.
Publicado: (2020)

Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers
por: Renzulli, Matteo, et al.
Publicado: (2022)

Update of the Bologna Experience in Radioembolization of Intrahepatic cholangiocarcinoma
por: Mosconi, Cristina, et al.
Publicado: (2023)

Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5)
por: Terzi, Eleonora, et al.
Publicado: (2022)

Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia
por: Ielasi, Luca, et al.
Publicado: (2023)

Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two Cases
por: Marinelli, Sara, et al.
Publicado: (2013)

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
por: Garajová, Ingrid, et al.
Publicado: (2023)

Direct antiviral agents for HCV infection and hepatocellular carcinoma: facts and FADs
por: Serio, Ilaria, et al.
Publicado: (2019)

Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study
por: Mosconi, Cristina, et al.
Publicado: (2016)

Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role
por: De Lorenzo, Stefania, et al.
Publicado: (2020)

Imaging of Colorectal Liver Metastases: New Developments and Pending Issues
por: Renzulli, Matteo, et al.
Publicado: (2020)

A New Quantitative Classification of the Extrahepatic Biliary Tract Related to Cystic Duct Implantation
por: Renzulli, Matteo, et al.
Publicado: (2020)

Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art
por: Monaco, Giovanni, et al.
Publicado: (2023)

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
por: Garajová, Ingrid, et al.
Publicado: (2023)

Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification
por: Vasuri, Francesco, et al.
Publicado: (2019)

Hemostatic powder for the intraductal treatment of biliary cancer bleeding
por: Fuccio, Lorenzo, et al.
Publicado: (2019)

Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
por: Gramantieri, Laura, et al.
Publicado: (2022)

Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?
por: Tovoli, Francesco, et al.
Publicado: (2020)

Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma
por: Giovannini, Catia, et al.
Publicado: (2020)

Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma
por: De Lorenzo, Stefania, et al.
Publicado: (2022)

The Influence of Gd-EOB-DTPA on T2 Signal Behavior: An Example from Clinical Routine
por: Franceschi, Paola, et al.
Publicado: (2022)

MRI Appearance of Focal Lesions in Liver Iron Overload
por: Pecorelli, Anna, et al.
Publicado: (2022)

Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments
por: Marasco, Giovanni, et al.
Publicado: (2020)

Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value
por: Mosconi, Cristina, et al.
Publicado: (2022)

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
por: Giovannini, Catia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_92ol169fonc7tb1k4b71r8d1i0